Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-030733)

Filing Details

Accession Number:: 0001181431-13-030733
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-24 16:45:54
Reporting Period:: 2013-05-23

Filing Date:: 2013-05-24
Accepted Time:: 2013-05-24 16:45:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1017491	Apricus Biosciences Inc.	APRI	Pharmaceutical Preparations (2834)	870449967

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1328822	Robert Steven Martin	11975 El Camino Real, Suite 300 San Diego CA 92130	Senior Vp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-05-23	20,000	$2.85	20,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant	Acquisiton	2013-05-23	20,000	$2.85	10,000	$3.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,000	2013-05-29	2018-05-29	No	4	P	Direct

Footnotes

Purchase in accordance with the Underwriting Agreement, by and between Apricus Biosciences, Inc. and Lazard Capital Markets LLC, dated May 23, 2013.
Each warrant is exercisable for 0.50 shares of common stock.